Wharton's Jelly and Exosome Supplier for McAllen Medspas

Vendor review for medspas operating under physician supervision

A medspa offering services involving Wharton's jelly or exosome products generally needs a supervising physician on record, and that physician is typically who reviews a new vendor before approving it for use in the practice. The review usually focuses on a certificate of analysis for the lot, a donor eligibility summary, and a plain description of processing and testing, since those are the documents a medspa would need to produce if asked about a specific product later. In a smaller market like McAllen, it is common for one physician to supervise more than one aesthetic location, so it helps to confirm during setup which location each account covers.

Setting up a verified account

Precision Biologics requires a National Provider Identifier to approve an account, and that NPI generally belongs to the supervising physician rather than the medspa as a business. Orders, reorders, and lot documentation all route through that verified identifier once the account is active.

Shipping and intake for aesthetic practices in South Texas

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and need prompt transfer to -80 C storage on arrival; lyophilized exosome products ship shelf-stable and store at room temperature as described in that lot's insert. A medspa without existing cryogenic storage should confirm freezer capacity before ordering a cryopreserved format, and should plan for a licensed staff member to be present when the shipment is expected.

• Confirm -80 C freezer capacity before ordering cryopreserved formats
• Have licensed staff present to receive and log the shipment
• Match the lot number on the packing slip before moving product into storage

Documentation and ongoing support

Medspas and aesthetic practices in Texas should verify the regulatory posture of any product directly with the Texas Medical Board and independent counsel rather than relying on supplier materials alone. Precision Biologics supports that review by providing registration and licensure documentation, certificates of analysis, and full ingredient disclosures to verified accounts, and by arranging a documentation-focused call between a requesting physician and a peer.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.